Synapse - Works

Results (13087)

A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma

Meeting Abstract

Blum, K. A.; Abramson, J.; Maris, M.; Flinn, I.; Goy, A.; Mertz, J.; Sims, R.; Garner, F.; Senderowicz, A.; Younes, A.
Annals of Oncology (2018)

Fulltext@MSK | Save

High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive B-NHL (TRANSCEND NHL 001 study): A defined composition CD19-directed CAR T cell product with potential for outpatient administration

Meeting Abstract

Abramson, J. S.; Siddiqi, T.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Wang, M.; Forero-Torres, A.; Albertson, T.; Dehner, C.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Intestinal microbiota injury during allo-HCT is generalizable across transplantation centers and is associated with increased mortality, broad-spectrum antibiotics, and decreased calorie intake

Meeting Abstract

Peled, J. U.; Gomes, A.; Buchan, M. L.; Stein-Thoeringer, C.; Slingerland, J.; Slingerland, A. E.; Weber, D.; Sung, A. D.; Maloy, M.; Peets, T.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Domination of the gut microbiota with enterococcus species early after allogeneic bone marrow transplantation is an important contributor to the development of acute graft-versus-host disease (GHVD) in mouse and man

Meeting Abstract

Stein-Thoeringer, C.; Peled, J. U.; Lazrak, A.; Slingerland, A. E.; Shono, Y.; Staffas, A.; Gomes, A.; Argyropoulos, K.; Docampo, M.; Xavier, J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials

Journal Article

D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Atkins, J.; Milhem, M. M.; Jahagirdar, B. N.; Antonescu, C. R.; Horvath, E.; Tap, W. D.; Schwartz, G. K.; more...
Lancet Oncology (2018)

Fulltext@MSK | Save

Host-related immunodeficiency in the development of multiple myeloma

Journal Article

Dosani, T.; Mailankody, S.; Korde, N.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; Kwok, M.; Kazandjian, D.; Costello, R.; more...
Leukemia and Lymphoma (2018)

Fulltext@MSK | Save

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: Phase 2 trial results

Journal Article

Richardson, P. G.; Bensinger, W. I.; Huff, C. A.; Costello, C. L.; Lendvai, N.; Berdeja, J. G.; Anderson, L. D. Jr; Siegel, D. S.; Lebovic, D.; Jagannath, S.; more...
British Journal of Haematology (2018)

Fulltext@MSK | Save

Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia

Journal Article

Seddon, A. N.; Chaim, J.; Akin, O.; Drill, E.; Michael, A. G.; Adel, N.; Tallman, M. S.
Leukemia Research (2018)

Fulltext@MSK | Save

Widespread use of measurable residual disease in acute myeloid leukemia practice

Journal Article

Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Estey, E.; Tallman, M. S.
Leukemia Research (2018)

Fulltext@MSK | Save

Management of relapsed and refractory multiple myeloma: Novel agents, antibodies, immunotherapies and beyond

Journal Article

Chim, C. S.; Kumar, S. K.; Orlowski, R. Z.; Cook, G.; Richardson, P. G.; Gertz, M. A.; Giralt, S.; Mateos, M. V.; Leleu, X.; Anderson, K. C.
Leukemia (2018)

Fulltext@MSK | Save